Operating Lease, Right-of-Use Asset of SEELOS THERAPEUTICS, INC. from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SEELOS THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
  • SEELOS THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $47,000, a 6.8% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SEELOS THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $47,000 +$3,000 +6.8% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $62,000 +$4,000 +6.9% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $15,000 -$57,000 -79% 31 Dec 2023 10-Q 14 Aug 2024 2024 Q2
Q3 2023 $30,000 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $44,000 +$31,000 +238% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $58,000 +$32,000 +123% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $72,000 +$33,000 +85% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q2 2022 $13,000 -$50,000 -79% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $26,000 -$48,000 -65% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $39,000 +$39,000 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q3 2021 $51,000 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $63,000 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $74,000 31 Mar 2021 10-K 04 Mar 2022 2021 FY
Q4 2020 $0 31 Dec 2020 10-Q 30 Apr 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.